当前位置：首页>产品中心>单抗/多抗>Anti-Human IL-17A/F Heterodimer Reference Antibody|抗人IL-17A/F异源二聚体参考抗体(靶标：人白细胞介素-17A/F异源二聚体)
Anti-Human IL-17A/F Heterodimer Reference Antibody|抗人IL-17A/F异源二聚体参考抗体(靶标：人白细胞介素-17A/F异源二聚体)
- 货号：RB9THS856066
- 价格：面议
- 点击：516
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Humanized |
| 克隆性 | Monoclonal |
| 抗体亚型 | IgG1-kappa |
| 纯度 | >95% as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 浓度 | 1 mg/ml |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 种属反应性 | Human |
| 靶标 | CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A |
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| 表达系统 | Mammalian Cells |
| 登录号 | Q16552 |
| 背景信息 | Ixekizumab is a humanized monoclonal antibody to interleukin-17A which acts as an antiinflammatory agent and is used to treat moderate-to-severe plaque psoriasis. Ixekizumab has not been linked to serum enzyme elevations during therapy or to instances of idiosyncratic acute liver injury. • The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond., PMID:30127781 • Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability., PMID:26431948 • IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment., PMID:37579542 • The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases., PMID:34863654 • IL-17 for therapy., PMID:28633806 • Association Between., PMID:35271496 • Vunakizumab: First Approval., PMID:39497021 • The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies., PMID:31278139 • IL-17A Modulates Peritoneal Macrophage Recruitment and M2 Polarization in Endometriosis., PMID:32117261 • Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F., PMID:32973785 |
| 别名 | RG4934, RO5310074, 1331830-76-2 |
| 种属 | Human |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
相关产品: